Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Authors / Paul Hahn

Paul Hahn

Paul Hahn MD, PhD is a Retina Specialist & Vitreoretinal Surgeon at NJ Retina, Teaneck, NJ, USA. Disclosures. Advisory board: Alcon, Adverum, Alimera, Apellis, DORC, EyePoint, Genentech, IvericBio, Neurotech, Regeneron Consultant: Alcon, Adverum, Apellis, DORC, EyePoint, Genentech. Speaker: Eyepoint, Genentech Research funding: Alexion, Adverum, Apellis, Eyepoint, Genentech, Notal Vision, OcuTerra, Regeneron, Regenxbio, Samsara

  • Contributions

TKIs and the Expansion of Treatment Options for Wet AMD

December 2, 2024

A look at the phase III trials combining tyrosine kinase inhibitors (TKIs) with sustained-release platforms for longer-acting therapies for wet age-related macular degeneration

9 min read

TKIs and the Expansion of Treatment Options for Wet AMD

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: